# Collegium Pharmaceutical, Inc: filings

COLL · Nasdaq · CIK 1267565 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/coll.md) · [Financials](/companies/coll/financials.md) · [Filings](/companies/coll/filings.md) · [Insiders](/companies/coll/insiders.md)

## Reports and events: 192 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 371, 8-K 121, 144 73, SC 13G/A 44, 10-Q 35, 3 34, SC 13G 19, S-8 13, 10-K 11, DEF 14A 11, DEFA14A 11, SCHEDULE 13G/A 11, CORRESP 10, S-8 POS 10, SCHEDULE 13G 10, 4/A 8, 424B5 5, D 5, EFFECT 5, UPLOAD 5, ARS 4, SC TO-T/A 4, 8-K/A 3, S-1/A 3, S-3 3, 10-Q/A 2, 424B4 2, CT ORDER 2, S-1 2, SC 13D 2, SC 13D/A 2, 144/A 1, 305B2 1, 3/A 1, 8-A12B 1, CERTNAS 1, DRS 1, DRSLTR 1, FWP 1, PRE 14A 1, SC TO-C 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 16:05 ET | [8-K](/filings/0001104659-26-116876.md) | 1.02 Termination of a material agreement | 0001104659-26-116876 |
| 2026-08-13 | 07:30 ET | [8-K](/filings/0001104659-26-095464.md) | 8.01 Other events | 0001104659-26-095464 |
| 2026-08-06 | 07:34 ET | [10-Q](/filings/0001628280-26-053851.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053851 |
| 2026-08-06 | 07:33 ET | [8-K](/filings/0001628280-26-053849.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001628280-26-053849 |
| 2026-06-30 | 16:05 ET | [8-K/A](/filings/0001104659-26-079323.md) | 9.01 Financial statements and exhibits | 0001104659-26-079323 |
| 2026-05-15 | 16:10 ET | [8-K](/filings/0001104659-26-062536.md) | 5.07 Shareholder vote results | 0001104659-26-062536 |
| 2026-05-12 | 07:43 ET | [8-K](/filings/0001104659-26-059018.md) | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-059018 |
| 2026-05-07 | 07:34 ET | [10-Q](/filings/0001628280-26-031697.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031697 |
| 2026-05-07 | 07:33 ET | [8-K](/filings/0001628280-26-031694.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-031694 |
| 2026-04-07 | 16:02 ET | [DEF 14A](/filings/0001628280-26-024063.md) | Proxy statement, period 2026-05-14 | 0001628280-26-024063 |
| 2026-04-07 | 16:01 ET | [8-K](/filings/0001628280-26-024061.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-024061 |
| 2026-03-19 | 17:06 ET | [8-K](/filings/0001104659-26-032166.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-032166 |
| 2026-02-26 | 07:34 ET | [10-K](/filings/0001628280-26-011992.md) | Annual report, period 2025-12-31 | 0001628280-26-011992 |
| 2026-02-26 | 07:32 ET | [8-K](/filings/0001628280-26-011990.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-011990 |
| 2026-01-08 | 08:06 ET | [8-K](/filings/0001104659-26-001953.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-001953 |
| 2025-12-30 | 08:05 ET | [8-K](/filings/0001104659-25-125026.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-125026 |
| 2025-11-06 | 07:35 ET | [10-Q](/filings/0001104659-25-107391.md) | Quarterly report, period 2025-09-30 | 0001104659-25-107391 |
| 2025-11-06 | 07:33 ET | [8-K](/filings/0001104659-25-107389.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-107389 |
| 2025-08-07 | 07:35 ET | [10-Q](/filings/0001558370-25-010649.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010649 |
| 2025-08-07 | 07:32 ET | [8-K](/filings/0001558370-25-010647.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-010647 |
| 2025-07-07 | 08:05 ET | [8-K](/filings/0001104659-25-065981.md) | 8.01 Other events | 0001104659-25-065981 |
| 2025-05-19 | 16:05 ET | [8-K](/filings/0001104659-25-050435.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-050435 |
| 2025-05-12 | 08:10 ET | [8-K](/filings/0001104659-25-047040.md) | 8.01 Other events | 0001104659-25-047040 |
| 2025-05-08 | 16:03 ET | [10-Q](/filings/0001558370-25-006960.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006960 |
| 2025-05-08 | 16:01 ET | [8-K](/filings/0001558370-25-006957.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-006957 |
| 2025-03-28 | 16:01 ET | [DEF 14A](/filings/0001558370-25-003983.md) | Proxy statement, period 2025-05-15 | 0001558370-25-003983 |
| 2025-03-17 | 07:05 ET | [8-K](/filings/0001104659-25-024185.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-25-024185 |
| 2025-02-27 | 16:03 ET | [10-K](/filings/0001558370-25-001801.md) | Annual report, period 2024-12-31 | 0001558370-25-001801 |
| 2025-02-27 | 16:01 ET | [8-K](/filings/0001558370-25-001799.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-001799 |
| 2025-02-05 | 08:05 ET | [8-K](/filings/0001104659-25-009384.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-009384 |
| 2025-01-08 | 08:05 ET | [8-K](/filings/0001104659-25-001873.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-001873 |
| 2024-11-14 | 16:01 ET | [8-K/A](/filings/0001104659-24-118858.md) | 9.01 Financial statements and exhibits | 0001104659-24-118858 |
| 2024-11-07 | 16:06 ET | [10-Q](/filings/0001558370-24-014858.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014858 |
| 2024-11-07 | 16:01 ET | [8-K](/filings/0001104659-24-115287.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-115287 |
| 2024-09-04 | 08:03 ET | [8-K](/filings/0001104659-24-096647.md) | 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-096647 |
| 2024-08-08 | 16:04 ET | [10-Q](/filings/0001558370-24-011586.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011586 |
| 2024-08-08 | 16:01 ET | [8-K](/filings/0001558370-24-011583.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-011583 |
| 2024-07-29 | 06:02 ET | [8-K](/filings/0001104659-24-083126.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-083126 |
| 2024-06-13 | 08:05 ET | [8-K](/filings/0001104659-24-071070.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-071070 |
| 2024-05-24 | 16:05 ET | [8-K](/filings/0001104659-24-065119.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-065119 |
| 2024-05-20 | 16:05 ET | [8-K](/filings/0001104659-24-063396.md) | 5.07 Shareholder vote results | 0001104659-24-063396 |
| 2024-05-13 | 08:05 ET | [8-K](/filings/0001104659-24-060235.md) | 8.01 Other events | 0001104659-24-060235 |
| 2024-05-10 | 08:02 ET | [8-K](/filings/0001104659-24-059656.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-059656 |
| 2024-05-09 | 16:07 ET | [10-Q](/filings/0001558370-24-007601.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007601 |
| 2024-05-09 | 16:04 ET | [8-K](/filings/0001558370-24-007596.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-007596 |
| 2024-04-29 | 08:05 ET | [8-K](/filings/0001104659-24-053506.md) | 1.01 Entry into a material agreement | 0001104659-24-053506 |
| 2024-04-11 | 08:00 ET | [8-K](/filings/0001104659-24-046091.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-046091 |
| 2024-04-05 | 16:01 ET | [DEF 14A](/filings/0001558370-24-004778.md) | Proxy statement, period 2024-05-16 | 0001558370-24-004778 |
| 2024-02-22 | 16:03 ET | [10-K](/filings/0001558370-24-001526.md) | Annual report, period 2023-12-31 | 0001558370-24-001526 |
| 2024-02-22 | 16:01 ET | [8-K](/filings/0001558370-24-001524.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-001524 |

Page 1 of 4. [Older](/companies/coll/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 11:26 ET. No prices; not investment advice.